Epidermal Growth Factor Receptor: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 34: | Line 34: | ||
* [[Gefitinib]] or Iressa<br /> | * [[Gefitinib]] or Iressa<br /> | ||
* [[Erlotinib]] or Tarceva<br /> | * [[Erlotinib]] or Tarceva<br /> | ||
EGFR inhibitors used in non-small cell lung cancer treatment<br /> | |||
* [[Osimertinib]] or Iressa<br /> | |||
EGFR inhibitors used in renal cell carcinoma and kidney cancer treatment<br /> | EGFR inhibitors used in renal cell carcinoma and kidney cancer treatment<br /> | ||
* [[Sorafenib]] or Nexavar<br /> | * [[Sorafenib]] or Nexavar<br /> | ||